Starpharma’s loss, strong financial position Biotechnology company Starpharma‘s loss narrowed during FY24 by 48 percent from $15.6 million to $8.2 million. Net cash outflow of $11.8 million was down $7.4 million from FY23 on revenue up 132 percent to $9.8 million. Revenue included a one-time $6.6 million cash payment from Mundipharma on termination of a…
Environmental Clean Technologies in lignite-based soil improvement hook up Industrial technology group Environmental Clean Technologies has signed a Heads of Agreement (HoA) with ESG Agriculture for the development and offtake of soil health products. This HoA is a precursor to a Joint Venture (JV) between the companies in developing a lignite-based nitrogen soil health product,…
Australian-Singaporean bioresorbable implants manufacturer Osteopore has reached key milestones in its development of 3D printed bioresorbable dental implants to aid bone healing and boost the success of tooth implant surgeries. The company is developing the implants in an $18.7 million programme with the National Dental Centre Singapore (NDCS) and the Agency for Science, Technology and…
Australian-Singaporean bioresorbable implants manufacturer Osteopore has announced a partnership with SingHealth to establish the company’s first Global Centre of Excellence (GCoE) for customised medical devices. The company said in an ASX statement on Tuesday that its wholly-owned Singaporean subsidiary, Osteopore International Pte Ltd, signed the non-exclusive Partnership Agreement with SingHealth, which it is expected to…
